Mechanistic approaches to chemoprevention of mutation and cancer

Lynnette R Ferguson1, Giorgio Bronzetti, Silvio De Flora

  • 1The University of Auckland, School of Medical Sciences, Faculty of Medical and Health Sciences, Discipline of Nutrition/ACSRC, Private Bag 92019, Auckland 1000, New Zealand.

Mutation Research
|August 13, 2005
PubMed

Insights

This special issue explores antimutagenesis and anticarcinogenesis, focusing on preventing cancer initiation and progression. Combining anticarcinogens may offer a realistic strategy to reduce the global burden of human cancers.

Area of Science:

  • Biomedical Sciences
  • Cancer Research
  • Molecular Biology

Background:

  • This issue focuses on antimutagenesis and anticarcinogenesis, addressing cancer prevention and treatment.
  • It reviews mechanisms including cancer initiation prevention, tumor angiogenesis inhibition, and selective estrogen receptor modulators.

Discussion:

  • The role of antimutagens in preventing cancer initiation is examined.
  • Mechanisms involving tumor angiogenesis inhibition and selective estrogen receptor modulators are discussed.
  • New screening methods and biomarkers for cancer prevention are elucidated.

Key Insights:

  • Antimutagens can prevent cancer initiation through various mechanisms.
  • Inhibiting tumor angiogenesis and using selective estrogen receptor modulators are potential anticarcinogenic strategies.
  • Novel screening methods and biomarkers are crucial for advancing cancer prevention research.

Outlook:

  • Long-term combination therapy with anticarcinogens shows promise for reducing cancer incidence.
  • Further research into these mechanisms could lead to effective cancer prevention strategies.
  • The development of new biomarkers will aid in early detection and personalized prevention.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair01:36

Mismatch Repair

Overview